UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Ulland Investment Advisors LLC

Ulland Investment Advisors LLC increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.2% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 12,485 shares of the healthcare conglomerate’s stock after acquiring an additional 153 shares during the quarter. UnitedHealth Group accounts for 4.0% of Ulland Investment Advisors LLC’s portfolio, making the stock its 10th biggest position. Ulland Investment Advisors LLC’s holdings in UnitedHealth Group were worth $6,316,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also bought and sold shares of the stock. Kathleen S. Wright Associates Inc. bought a new position in shares of UnitedHealth Group during the third quarter valued at about $27,000. Global Wealth Strategies & Associates boosted its stake in shares of UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after buying an additional 32 shares during the last quarter. West Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group during the third quarter valued at approximately $32,000. RPg Family Wealth Advisory LLC purchased a new position in UnitedHealth Group in the third quarter worth $37,000. Finally, Quarry LP raised its stake in shares of UnitedHealth Group by 132.1% during the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after purchasing an additional 37 shares during the period. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $510.03 on Tuesday. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The firm’s fifty day moving average price is $549.37 and its 200-day moving average price is $563.70. The stock has a market cap of $469.37 billion, a P/E ratio of 32.91, a price-to-earnings-growth ratio of 1.39 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company’s revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the company earned $5.83 EPS. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 29.77 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.65%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

Analyst Ratings Changes

A number of research firms recently issued reports on UNH. Oppenheimer raised their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Barclays dropped their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday. Deutsche Bank Aktiengesellschaft boosted their target price on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a report on Friday, January 10th. Finally, Piper Sandler cut their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Two investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $627.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.